Attovia Therapeutics Launches Upsized $289 Million Initial Public Offering

Fenwick & West has advised Attovia Therapeutics. Cooley LLP has advised the underwriters. Attovia Therapeutics, a clinical-stage biopharmaceutical company, has announced the pricing of its upsized…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here